PubMed=6300668; DOI=10.1016/0027-5107(83)90097-0
Syuiti Abe, Nobuo Nemoto, Motomichi Sasaki;
Sister-chromatid exchange induction by indirect mutagens/carcinogens, aryl hydrocarbon hydroxylase activity and benzo[alpha]pyrene metabolism in cultured human hepatoma cells.
Mutat. Res. 109:83-90(1983)

PubMed=2856442
Fumiaki Sasaki, Hiroshi Kameda, Yoshinobu Hata, Junichi Uchino;
Establishment of the human hepatocellular carcinoma cell line and its characteristics.
Hum. Cell 1:89-91(1988)

PubMed=2543326
Yoshinobu Hata, Motomu Igarashi, Naoyuki Takada, Tsutomu Namieno, Fumiaki Sasaki, Yoshie Une, Junichi Uchino, Masaharu Kajiwara;
Development of a new therapeutic method in hepatocellular carcinoma using a culture system -- the intensifying effect of human epidermal growth factor (hEGF) on the antitumor action of antitumor agents.
Gan To Kagaku Ryoho 16:1874-1879(1989)

PubMed=7874267; DOI=10.1007/BF02349278
Shigeo Ikuta, Fumio Itoh, Yuji Hinoda, Minoru Toyota, Yusuke Makiguchi, Kohzoh Imai, Akira Yachi;
Expression of cytoskeletal-associated protein tyrosine phosphatase PTPH1 mRNA in human hepatocellular carcinoma.
J. Gastroenterol. 29:727-732(1994)

PubMed=12029633; DOI=10.1053/jhep.2002.33683
Kohichiroh Yasui, Shigeki Arii, Chen Zhao, Issei Imoto, Masakazu Ueda, Hisaki Nagai, Mitsuru Emi, Johji Inazawa;
TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
Hepatology 35:1476-1484(2002)